Skip to main content

Table 3 Participant demographics displayed per lustrum of age. Data presented as Mean(SD), Median(IR), or geometric mean

From: The difference in sleep, sedentary behaviour, and physical activity between older adults with ‘healthy’ and ‘unhealthy’ cardiometabolic profiles: a cross-sectional compositional data analysis approach

Variable

Age Group (years)

Pooled

60–65

66–71

72–77

78–83

84+

n

93

10

19

31

24

9

Female (%)

55

90

47

54

54

33

Covariates

 Directly CVD Meds (n∙day− 1)a

1.17 (1.52)

0.30 (0.48)

0.74 (1.37)

1.39 (1.61)

1.39 (1.53)

1.78 (1.92)

 (In)directly CVD Meds (n∙day−1)b

1.62 (1.81)

0.70 (0.67)

1.05 (1.51)

1.81 (1.97)

2.04 (1.92)

2.11 (1.96)

 Inn+ (In)directly CVD Meds (mg∙day−1)c

157.86 (486.49)

293.40 (797.89)

54.71 (73.39)

93.19 (293.99)

136.67 (323.71)

494.88 (1085.38)

 BP Meds (mg∙day−1)

9.81 (50.79)

3.50 (6.73)

5.47 (13.29)

2.35 (4.89)

8.05 (16.71)

53.00 (154.35)

 Lipid-Lowering Meds (mg∙day−1)

8.12 (16.58)

11.00 (16.63)

9.41 (15.60)

3.57 (10.96)

13.33 (23.09)

4.44 (13.33)

Cardio-metabolic Parameters

 Triglyceride (mmol∙l−1)

1.77 (0.81)m

2.09 (0.86)m

1.51 (0.84)m

1.73 (0.68)m

1.88 (0.56)m

1.89 (0.57)m

 Total Cholesterol (mmol∙l−1)

5.44 (1.39)m

6.06 (0.95)

5.64 (1.08)

5.45 (1.07)

5.64 (0.89)

5.27 (0.66)

 Glucose (mmol∙l−1)

5.72 (1.10)m

5.81 (0.81)m

5.85 (1.35)m

5.60 (1.33)m

5.65 (1.38)m

6.00 (1.11)m

 HbA1c (%)

5.29 (0.31)

5.18 (0.22)

5.30 (0.22)

5.34 (0.36)

5.24 (0.33)

5.38 (0.32)

 LPL (pg∙mL−1)

113.02 (147.80)m

174.35 (277.28)m

119.13 (127.16)m

83.41 (123.97)m

117.88 (147.07)m

247.58 (332.56)m

 IL-6 (pg∙mL−1)

2.72 (2.77)m

3.11 (1.85)m

2.39 (2.85)m

2.55 (3.29)m

2.36 (2.98)m

4.14 (6.00)m

 PIIINP (pg∙mL−1)

229.21 (247.97)m

205.05 (239.21)m

229.21 (208.30)m

316.92 (228.81)m

167.19 (248.76)m

256.99 (406.27)m

sleep, sedentary behaviour, and physical activity parameters

 Sleep (hrs∙day−1)

8.43 (0.77) 8.40g

7.88 (0.83) 7.84g

8.49 (0.53) 8.48g

8.41 (0.73) 8.35g

8.62 (0.79) 8.58g

8.50 (1.04) 8.45g

 SB (hrs∙day−1)

9.65 (1.33) 9.56g

9.81 (1.31) 9.73g

9.34 (1.38) 9.25g

9.61 (1.36) 9.53g

9.59 (1.29) 9.51g

10.49 (1.15) 10.44g

 Standing (hrs∙day−1)

1.09 (0.41) 1.02g

1.19 (0.30) 1.14g

1.16 (0.43) 1.08g

1.11 (0.39) 1.03g

1.08 (0.43) 1.00g

0.89 (0.43) 0.81g

 LIPA (hrs∙day−1)

1.97 (0.63) 1.86g

2.11 (0.49)

2.05g

1.86 (0.59) 1.78g

2.06 (0.63) 1.95g

1.99 (0.68) 1.88g

1.73 (0.77) 1.57g

 sMVPA (hrs∙day−1)

2.57 (0.64) 2.49g

2.68 (0.58) 2.62g

2.86 (0.56) 2.80g

2.55 (0.59) 2.49g

2.53 (0.69) 2.42g

2.07 (0.67) 1.96g

10MVPA (hrs∙day−1)

0.08 (0.20)m 0.06g

0.06 (0.16)m 0.07g

0.15 (0.29)m 0.13g

0.08 (0.21)m 0.05g

0.09 (0.22)m 0.07g

0.07 (0.13)m 0.03g

10MVPAd (hrs∙day−1)

0.48 (0.36) 0.40g

0.53 (0.30) 0.43g

0.47 (0.22) 0.43g

0.54 (0.51) 0.43g

0.39 (0.17) 0.35g

0.28 (0.09) 0.27g

  1. a Participants are currently prescribed an amount of medication that reduces the risk or treats CVD (i.e. statins, warfarin). b Participants are currently prescribed a medication that may affect the cardiovascular system either directly or as a side effect. c Participants are currently prescribed a medication that may affect the cardiovascular system either directly or as a side effect, including inflammatory medication. d Excluding 49 participants who accumulated < 10 min of 10MVPA in a week (variable not used in CoDA). m Median (IR). g Geometric mean